Spain / Stroke / Humans / Female / Atrial Fibrillation / Anticoagulants / Aged / Middle Aged / Budgets / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Benzimidazoles / Anticoagulants / Aged / Middle Aged / Budgets / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Benzimidazoles
Spain / Stroke / Humans / Female / Atrial Fibrillation / Anticoagulants / Aged / Middle Aged / Budgets / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Benzimidazoles / Anticoagulants / Aged / Middle Aged / Budgets / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Benzimidazoles
Economics / Public Health / Health Policy / Spain / Health Care reform / Health Care Rationing / Health Expenditures / Budgets / Cost Savings / Gross Domestic Product (GDP) / Health Care Rationing / Health Expenditures / Budgets / Cost Savings / Gross Domestic Product (GDP)
Law / Developing Country / United States / Physicians / Empirical Research / Professional Autonomy / Malpractice / Public Administration and Policy / Budgets / Public health systems and services research / Employee Discipline / State government / Empirical Analysis / Professional Autonomy / Malpractice / Public Administration and Policy / Budgets / Public health systems and services research / Employee Discipline / State government / Empirical Analysis
